RRAS and neoplasm: Recent study showed that miR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma, while miR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras34,35.